Aquestive Therapeutics CFO John Maxwell's 2020 pay jumps 24% to $1.3M
Aquestive Therapeutics reports 2020 executive compensation
By ExecPay News
Published: May 5, 2021
Aquestive Therapeutics reported fiscal year 2020 executive compensation information on May 5, 2021.
In 2020, three executives at Aquestive Therapeutics received on average a compensation package of $1.1M, a 29% decrease compared to previous year.
Average pay of disclosed executives at Aquestive Therapeutics
John T. Maxwell, Chief Financial Officer, received $1.3M in total, which increased by 24% compared to 2019.
Keith J. Kendall, Chief Executive Officer, received a compensation package of $1.3M, which decreased by 51% compared to previous year. 43% of the compensation package, or $550K, was in salary.
Daniel Barber, Chief Operating Officer, earned $840K in 2020, a 30% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on May 5, 2021.